FranΓ§aisπ See the interactive version (live chart) β
For Crocs, we replayed every analyst price target of the past 12 months and measured the real outcome: 26% were profitable, average return +12% (117 calls). At 3 months: +6% average return (42% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Piper Sandler | 15 | 40% | +40% |
| Wedbush | 13 | 31% | +10% |
| Stifel | 11 | 18% | +3% |
| Baird | 9 | 22% | +23% |
| B of A Securities | 8 | 38% | +8% |
Is Crocs overvalued, and is it a good time to buy Crocs right now? If you're wondering, here's a recap to make up your own mind: Crocs's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Crocs | Sector median (Consumer Discretionary) |
|---|---|---|
| P/E | 13.2 | 19.3 |
| Forward P/E | 9.5 | 15.3 |
| Net margin | 15% | 9% |
π Crocs trades below its sector median (13.2 vs 19.3) β potentially undervalued, or lower expected growth.
π P/E, PEG, marginβ¦: see the glossary
The analyst consensus on Crocs (CROX) is "Buy" (11 bullish, 1 bearish calls over 12 months). This is not advice: historically, 26% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $150 (-0% vs $150), ranging from $120 to $160 (7 analysts).
Over 1 year, 26% of analyst targets on Crocs were profitable, for an average return of +12% (across 117 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $150 within 12 months, i.e. -0% vs the current price. The most bullish targets $160, the most cautious $120.
Note: analyst targets are 12-month (median $150, -0%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (26%), and the stock's past trajectory.
Its P/E is 13.2, forward P/E 9.5. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Crocs β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.